The administration of rhBmal1 reduces sleep deprivation-induced anxiety and cognitive impairment in mice
CONCLUSIONS: rhBmal1 treatment might serve as a potential therapy for mitigating sleep deprivation-related unfavorable symptoms.PMID:37640026 | DOI:10.1080/15622975.2023.2252499
Source: The World Journal of Biological Psychiatry - Category: Psychiatry Authors: Linqing Qi Youdi Cheng Shan Sun Hao Wan Source Type: research
More News: Allergy & Immunology | Anxiety | Brain | Environmental Health | Genetics | Neurology | Psychiatry | Sleep Disorders | Sleep Medicine